Phyla is developing alternative therapies for antibiotics.
Phyla's investors include Willow Growth Partners, Squared Circles, Progression, Newchip Accelerator, Shiseido.
Phyla is headquartered in San Francisco, United States.
Phyla is developing alternative therapies for antibiotics.
Phyla is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Phyla — Funding & Investors." VCBacked, December 7, 2023, https://www.vcbacked.co/company/phyla. Accessed September 14, 2026.
VCBacked. (2023). Phyla — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/phyla
{{cite web |title=Phyla — Funding & Investors |url=https://www.vcbacked.co/company/phyla |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated